Prognostic significance of standardized uptake value and metabolic tumour volume on 18F-FDG PET/CT in oropharyngeal squamous cell carcinoma
Prognostic significance of standardized uptake value and metabolic tumour volume on 18F-FDG PET/CT in oropharyngeal squamous cell carcinoma
复制标题
DOI:
10.1007/s00259-015-3051-4
复制
发表时间:
2015-08-01
影响因子:
9.1
通讯作者:
Kim, Sang Yoon
中科院分区:
文献类型:
--
作者:
Kim, Ji Won;Oh, Jungsu S.;Kim, Sang Yoon
Purpose Standardized uptake value (SUV) and metabolic tumour volume (MTV) measured by F-18-FDG PET/CT are emerging prognostic biomarkers in human solid cancers. However, their prognostic significance in oropharyngeal squamous cell carcinoma (OPSCC) has been investigated in only a few studies and with small cohorts. In the present study we evaluated the ability of SUV, MTV, and total lesion glycolysis (TLG) measured on pretreatment F-18-FDG PET/CT to predict recurrence and survival outcomes in OPSCC.Methods The study included 221 patients with OPSCC who underwent pretreatment F-18-FDG PET/CT imaging and received definitive treatment at our tertiary referral centre. The PET imaging parameters SUVmax, SUVpeak, MTV and TLG were measured in primary tumours with focal F-18-FDG uptake. Clinical and imaging variables significantly associated with overall survival (OS) and disease-free survival (DFS) were identified by univariate and multivariate analyses using the Cox proportional hazards model.Results Overall 5-year OS and DFS rates were 72.0 % and 79.5 %, respectively, during a median follow-up of 61 months (range 18 - 122 months). The cut-off values of tumour SUVmax, SUVpeak, MTV and TLG for prediction of DFS were 7.55, 6.80, 11.06 mL and 78.56 g, respectively. Univariate analyses showed that age > 60 years, advanced tumour stage, and high tumour SUVmax, SUVpeak, MTV and TLG were significantly associated with decreased OS and DFS (P < 0.05 each). Age, tumour SUVmax and MTV remained independent variables for OS and DFS (P < 0.05 each) in the multivariate analyses.Conclusion SUVmax and MTV measured on pretreatment F-18-FDG PET/CT may be useful in predicting the clinical outcomes in OPSCC patients.